Prognostic implications of metabolism-related genes in acute myeloid leukemia
A novel metabolic gene signature was developed to stratify risk and predict prognosis in AML, serving as an independent prognostic factor. CA13 was identified as a potential therapeutic target. This study provides new insights into the prognostic and therapeutic implications of metabolic genes in AML.
Authors
- Mianyang Li (ORCID: https://orcid.org/0009-0000-6093-4890)
- Chengliang Yin (ORCID: https://orcid.org/0000-0001-8056-9384)
- Na Ren (ORCID: https://orcid.org/0000-0002-4783-8295)
- Ruibin Li (ORCID: https://orcid.org/0000-0001-6471-7658)
- Chengbin Wang (ORCID: https://orcid.org/0000-0001-5209-5548)
- Jianan Wang (ORCID: https://orcid.org/0009-0007-8301-780X)
Institutions
- Chinese PLA General Hospital (CN)
- General Hospital of Shenyang Military Region (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2024-10-03
- DOI
- https://doi.org/10.3389/fgene.2024.1424365
- Citations
- 3
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36